Table 3 Risk factors associated with abnormality detected upon additional cardiac investigation

73.3 ± 8.4

69.4 ± 9.0

-

0.004

-

1.05

1.02–1.09

0.005

35 (70%)

167 (51.5%)

5.94

0.015

2.4

2.19

1.15–4.17

0.020

15 (30%)

157 (48.5%)

5.94

0.015

-2.4

0.46

0.24–0.87

0.020

31.4 ± 5.9

31.2 ± 5.3

-

0.880

-

1.01

0.95–1.06

0.870

9 (18%)

47 (14.5%)

0.42

0.519

0.6

1.30

0.59–2.84

0.520

37 (74%)

207 (63.9%)

1.95

0.162

1.4

1.61

0.82–3.15

0.170

30 (60.0%)

186 (57.4%)

0.12

0.730

0.3

1.11

0.61–2.04

0.730

6 (12.0%)

16 (4.9%)

9.52

0.009

2.0

3.39

1.22–9.42

0.020

18 (36.0%)

73 (22.5%)

9.52

0.009

2.1

2.23

1.16–4.29

0.020

6 (12.0%)

36 (11.1%)

0.03

0.853

0.2

1.09

0.43–2.74

0.850

7 (14.0%)

37 (11.4%)

0.28

0.598

0.5

1.26

0.53–3.01

0.600

2 (4.0%)

12 (3.7%)

0.01

0.918

0.1

1.08

0.24–4.99

0.920

4 (8.0%)

39 (12.0%)

0.69

0.405

-0.8

0.64

0.22–1.86

0.410

16 (32%)

116 (35.8%)

0.27

0.601

-0.5

0.84

0.45–1.59

0.600

0 (0.0%)

8 (2.5%)

1.26

0.261

-1.1

0.37

0.02–6.49

0.500

6 (12.0%)

22 (6.8%)

1.70

0.193

1.3

1.87

0.72–4.87

0.200

11 (22%)

63 (19.4%)

0.18

0.673

0.4

1.14

0.56–2.34

0.710

5 (10.0%)

20 (6.2%)

1.02

0.313

1.0

1.69

0.60–4.73

0.320

6 (12.0%)

49 (15.1%)

0.34

0.562

-0.6

0.79

0.32–1.94

0.610

2 (4.0%)

5 (1.5%)

1.42

0.233

1.2

2.66

0.50–14.09

0.250

8 (16.0%)

19 (5.9%)

6.64

0.010

2.6

2.45

1.04–5.74

0.040

4 (8.0%)

10 (3.1%)

2.90

0.088

1.7

2.73

0.82–9.07

0.100

3 (6.0%)

20 (6.2%)

0.47

0.790

0.0

0.97

0.28–3.37

0.970

16 (32.0%)

56 (17.3%)

6.03

0.014

2.5

2.25

1.16–4.36

0.020

24 (48.0%)

91 (28.1%)

8.07

0.005

2.8

2.36

1.29–4.33

0.005

58.9 ± 11.6

64.6 ± 7.3

-

0.002

-

0.93

0.89–0.96

<0.001